Detalles de la búsqueda
1.
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic, Omalizumab, in Severe Asthma in Adults: Results of the SoMOSA Study.
Am J Respir Crit Care Med
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38635834
2.
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
N Engl J Med
; 385(13): 1172-1183, 2021 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192426
3.
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
Epidemiol Infect
; 152: e37, 2024 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250791
4.
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Clin Infect Dis
; 76(3): 398-407, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36210481
5.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Lancet
; 398(10318): 2258-2276, 2021 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34863358
6.
Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
Respir Res
; 23(1): 26, 2022 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144620
7.
Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
BMC Pulm Med
; 15: 47, 2015 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25927483
8.
Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-two case reports.
Ann Hepatol
; 12(4): 629-33, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23813142
9.
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2.
ERJ Open Res
; 9(5)2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37868151
10.
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.
Lancet Infect Dis
; 23(9): 1007-1019, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348519
11.
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
J Infect
; 87(1): 18-26, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085049
12.
Investigating the Accuracy of the Digihaler, a New Electronic Multidose Dry-Powder Inhaler, in Measuring Inhalation Parameters.
J Aerosol Med Pulm Drug Deliv
; 35(3): 166-177, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964657
13.
Musculoskeletal tuberculosis in Bradford : 12 years of outcomes and observations in a high-incidence region of the UK.
Bone Jt Open
; 3(5): 432-440, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608348
14.
Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma.
Chest
; 162(2): 297-308, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248549
15.
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.
Lancet Respir Med
; 10(5): 435-446, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026180
16.
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Lancet Infect Dis
; 22(8): 1131-1141, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35550261
17.
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
J Infect
; 84(6): 795-813, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405168
18.
Tuberculosis in UK cities: workload and effectiveness of tuberculosis control programmes.
BMC Public Health
; 11: 896, 2011 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22122757
19.
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
J Infect
; 86(5): 540-541, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37055303
20.
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
Int J Chron Obstruct Pulmon Dis
; 11: 1425-34, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27418815